tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX

Shield Therapeutics (STX) Technical Analysis

7 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
2Neutral
16Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is -0.54, suggesting Shield Therapeutics PLC is a Sell.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 2.45, while Shield Therapeutics PLC’s (STX) share price is 2.025p, making it a Sell.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 3.66, while Shield Therapeutics PLC’s (STX) share price is 2.025p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

Apr 26, 2024, 02:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.79
1.85
1.93
1.99
2.06
2.12
2.20
Fibonacci
1.85
1.90
1.94
1.99
2.04
2.07
2.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Apr 26, 2024, 02:25 PM
Period
Simple
Exponential
MA5
2.04Sell
2.04Sell
MA10
2.10Sell
2.12Sell
MA20
2.23Sell
2.45Sell
MA50
4.07Sell
3.66Sell
MA100
5.28Sell
4.87Sell
MA200
6.99Sell
6.16Sell
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 2.12, while Shield Therapeutics PLC’s (STX) share price is 2.025p, making it a Sell.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 4.87, while Shield Therapeutics PLC’s (STX) share price is 2.025p, making it a Sell.
Shield Therapeutics PLC’s (STX) stock price is 2.025p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 4.07, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 2.025p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 5.28, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 2.025p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 6.99, creating a Sell signal.

Shield Therapeutics (STX) Technical Indicators

Apr 26, 2024, 02:25 PM
Name
Value
Implied Action
RSI (14)
21.63
Buy
STOCH (9,6)
28.11
Neutral
STOCHRSI (14)
14.05
Buy
MACD (12,26)
-0.54
Sell
ADX (14)
63.79
Sell
Williams %R
-82.86
Buy
CCI (14)
-106.58
Buy
ATR (14)
0.22
-
Ultimate Oscillator
46.48
Neutral
ROC
-19.84
Sell
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 21.63, creating a Buy signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 63.79, creating a Sell signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is -106.58, creating a Buy signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is -19.84, creating a Sell signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Strong Sell.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 21.63, which suggests STX is a Buy.
      What is STX’s MACD?
      STX’s MACD is -0.54, which suggests STX is a Sell.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 2.04, which suggests STX is a Sell.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 2.23, which suggests STX is a Sell.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 4.07, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 6.99, which suggests STX is a Sell.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -82.86, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is -106.58, which suggests STX is a Buy.
                    What is the share price of Shield Therapeutics PLC?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis